Position in ORKA
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$33,578,259
+$28,668,796 QoQ
Shares Held
352,824
+252.5% QoQ
Ownership
0.533%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#42
of 254 holders
Holding Since
Mar 2020
23 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ORKA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026BANK OF AMERICA CORP /DE/ holds $10,050,306,032 across 338 Biotechnology names. ORKA ranks #63 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,039,178 | $1,509,650,884 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,291,053 | $805,023,185 | |
| 3 | CYTK |
Cytokinetics Inc
|
4,635,709 | $394,916,048 | |
| 4 | ARGX |
Argenx SE
|
400,234 | $371,325,094 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
994,476 | $299,367,107 | |
| 6 | JAZZ |
Jazz Pharmaceuticals plc
|
1,136,091 | $273,763,844 | |
| 7 | TVTX |
Travere Therapeutics, Inc.
|
4,568,341 | $259,527,450 | |
| 8 | RPRX |
Royalty Pharma plc
|
4,149,422 | $232,658,090 |
All Filings in ORKA
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $33,578,259 | 352,824 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $4,909,463 | 100,091 | Shares | Defined | 2026-05-18 | |
| 2025-12-31 | $4,221,333 | 139,272 | Shares | Defined | 2026-02-17 | |
| 2025-06-30 | $211,297 | 18,849 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $49,894 | 4,863 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $3,839 | 198 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $367 | 15 | Shares | Defined | 2024-11-14 | |
| 2023-12-31 ABIO | — | 43 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 ABIO | — | 31 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 ABIO | — | 31 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 ABIO | — | 31 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 ABIO | — | 65 | Shares | Defined | 2023-02-10 | |
| 2022-09-30 ABIO | — | 31 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 ABIO | — | 31 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 ABIO | — | 31 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 ABIO | — | 58 | Shares | Defined | 2022-02-08 | |
| 2021-09-30 ABIO | — | 105 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 ABIO | — | 31 | Shares | Defined | 2021-09-13 | |
| 2021-03-31 ABIO | — | 31 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 ABIO | — | 31 | Shares | Defined | 2021-02-10 | |
| 2020-09-30 ABIO | — | 31 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 ABIO | — | 43 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 ABIO | — | 31 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||